Two new variants of the Rhodococcus equi virulence plasmid, 90 kb type III and type IV, recovered from a foal in Japan     

Takai S  Murata N  Kudo R  Narematsu N  Kakuda T  Sasaki Y  Tsubaki S 《Veterinary microbiology》2001,80(4):373-381

Calves were vaccinated orally, subcutaneously or intraperitoneally with a smooth, plasmid-cured strain of Salmonella enterica serovar typhimurium, strain 81. Oral vaccination was not effective, as only 1/5 calves survived challenge with virulent S. typhimurium. Strain 81 was attenuated for calves, as only a slight rise in rectal temperatures was detected after vaccination. The organism was excreted by some calves in the faeces, but no signs of diarrhoea were observed after vaccination. After parenteral vaccination, strain 81 was able to reach the intestines, gastric associated lymphoid tissues and other internal lymphoid tissues and remained viable for up to 14 days in the bovine host. After oral challenge with a virulent strain, 9/10 vaccinated calves survived challenge as opposed to 4/10 control calves (p<0.5). Diarrhoea was present in all calves of the control groups, but in only 4/10 of the vaccinated calves. The clinical reactions of the vaccinated calves were milder than in the control calves, as the rises in rectal temperatures were lower, diarrhoea was less severe, and the challenge strain was present in fewer organs from vaccinated calves than control calves. This study showed that parenterally administered Salmonella vaccines can induce both mucosal and systemic immunity, and it is postulated that this capability of strain 81 is related to its colonisation of lymphoid tissues and other systemic and intestinal tissues. This study confirmed that plasmid-cured strains were attenuated in the bovine host and conferred significant protection after parenteral vaccination, but not oral vaccination.  相似文献   

“黄白散”对兔接种RHD疫苗后免疫功能的影响     

王新  邵红  朱战波  丁宝川 《畜牧与兽医》2001,33(4):8-10

在注射兔病毒性出血症 (RHD)疫苗后 ,30只兔随机分为 2组 ,试验组兔饲喂含 1 5 %黄白散的饲料。从接种到第 1 80天 ,每组取兔 8只 ,每隔 1 5d采血 1次 ,检测血凝抑制 (HI)抗体 ;在接种前 1天及接种后 5、 1 0、 1 7、 2 4、 31、 41、 5 1d ,每组取兔 1 0只 ,采血检测ANAE+淋巴细胞百分率 ;在 1 80、 2 4 0、 30 0d时 ,每组分别取兔 5只做攻毒保护试验。结果表明 :2组兔HI抗体峰值分别为 7 3log2和 9 8log2 ,差异极显著 (P <0 0 1 ) ;试验组疫苗保护期可延长 60d ;试验组ANAE+率从第 1 0天至 5 1天与对照组比较 ,差异极显著(P<0 0 1 )。所以黄白散可增强兔接种RHD疫苗后的特异性免疫功能 ,增强RHD疫苗的免疫效果。  相似文献   

油乳剂疫苗中硬脂酸铝含量与油相水相比例关系研究   总被引：2，自引：0，他引：2  

裴春生  何玉友  李群  唐艳琳  王玉莲 《中国兽药杂志》2005,39(2):21-23

进行了鸡新城疫、传染性支气管炎、产蛋下降综合征三联油乳剂疫苗生产中降低油相比例的试验.当油乳剂疫苗的油相中硬脂酸铝含量分别为2%、1%、0.5%,对应的油相:水相分别为3:1、2:1和1:1时进行的乳化试验结果表明:随着油相中硬脂酸铝含量降低,油相和水相的比例相应降低,呈正比例关系.当油相中硬脂酸铝含量与油/水比分别为2%和3:1、1%和2:1、0.5%和1:1时,制备的油苗质量均达到了国家标准.  相似文献   

转基因植物疫苗研究进展     

傅玲琳  帅江冰  许梓荣 《中国兽药杂志》2005,39(5):22-26

众多研究表明,病毒的抗原决定簇及细菌毒素亚单位均能在转基因植物中成功表达,并保持良好的免疫原性.与现有的疫苗生产体系相比,植物生产疫苗具有安全、经济、稳定、高效等优势.本文概述了利用不同受体植物生产疫苗的研究现状、免疫原性评价及免疫原基因的优化表达策略.  相似文献   

炭疽芽孢杆菌疫苗研究进展     

郑艳军  隋慧  郑艳霞 《中国兽药杂志》2005,39(7):46-50

炭疽病是一种人畜共患的烈性传染病.该病由炭疽杆菌所致,传播迅速,潜伏期短,死亡率高.炭疽杆菌在生物武器中占有重要地位.本文简述了现用疫苗及各国正在开发的新疫苗,探讨了疫苗研发的新思路,客观评价了人用炭疽疫苗的安全性及有效性.  相似文献   

山羊痘灭活疫苗免疫保护试验     

赵利平  魏学峰  陈九连  刘棋  郭建刚  巴特  苏丽琼  王家福 《中国兽药杂志》2005,39(8):21-23

将山羊痘GT4-STV42-56种毒在犊牛睾丸细胞上繁殖,收获毒液,用0.1%甲醛溶液灭活,加适量206佐剂,制成山羊痘油佐剂灭活疫苗.将疫苗以不同剂量皮下免疫接种不同种群的山羊.免疫后21 d,用AV40株强毒进行攻毒保护试验.结果显示,免疫剂量达0.5 mL时,疫苗对内蒙绒山羊的保护率为100%,对广西黑山羊的保护率为80%.实验表明,山羊痘灭活疫苗对山羊的免疫效果确实可靠.  相似文献   

牛病毒性腹泻／粘膜病O系弱毒冻干苗的试验生产和检验报告   总被引：5，自引：0，他引：5  

阎高峰  纪金春 《青海畜牧兽医杂志》1995,25(4):26-28

１９９２￣１９９４年共试生产牛病毒性腹泻／粘膜病（ＢＶＤ／ＭＤ）Ｏ系细胞培养弱毒冻干苗６０万头份，通过实验室内安全检验、效力检验、无菌检验、水份测定、真空度检验、物理性状检验及在玉树、称多和泽库三个疫病发生严重的县试用，证明《ＢＶＤ／ＭＤＯ系细胞培养弱毒冻干苗制造与检验试行办法》可行，并为制定该苗的制造与检验规程提供了依据。  相似文献   

Vaccination experiments on pregnant mice with E. coli vaccines prepared from septicaemic and enteropathogenic strains of E. coli     

A Dam 《Acta veterinaria Scandinavica》1973,14(5):691-699

Experiments have been carried out with vaccination of pregnant mice against E. coli, followed by i.p. challenge of the offspring at one week of age.With a septicaemic strain the results were highly significant, and the method is therefore recommendable for testing of vaccines against such strains of E. coli.Results were less clear-cut with enteropathogenic strains of E. coli. However, with mortality rates of 40 to 45 % in baby mice born by non-vaccinated mothers and less than 15 % in baby mice born by vaccinated mothers, the difference in percentage mortality seems sufficient to warrant the use of the method also in the control of vaccines against enteropathogenic E. coli strains.  相似文献   

Poxviruses as vaccine vectors   总被引：4，自引：0，他引：4  

Pastoret PP  Vanderplasschen A 《Comparative immunology, microbiology and infectious diseases》2003,26(5-6):343-355

The discovery of Jenner in 1798 founded the science of immunology and eventually led to smallpox eradication from the earth in 1980 after a world-wide vaccination campaign with vaccinia virus (another poxvirus) and paradoxically, despite the eradication of smallpox, there has been an explosion of interest in vaccinia virus in the eighties. This interest has stemmed in part from the application of molecular genetics to clone and express foreign genes from recombinant vaccinia viruses. Vaccinia is also gaining renewed interest due to bioterrorism.

These recombinant viruses have multiple applications in research and vaccinology and led to the development of vectored vaccines, such as the recombinant vaccinia rabies vaccine used to eliminate rabies in Western Europe and, more recently, in the United States. Secondly, alternative poxvirus vectors, such as avipox viruses, were proved to be even safer and efficacious non-replicating vectors (suiciole vectors) when used in non-avian species.  相似文献   

New gene-based approaches for an AIDS vaccine     

Puaux AL  Michel ML 《Comparative immunology, microbiology and infectious diseases》2003,26(5-6):357-372

Vaccine approaches against AIDS have focused on inducing cellular immune responses, since many studies revealed the role of T cell responses in the control of human immunodeficiency virus or simian immunodeficiency virus (SIV) infections. The experimental infection of rhesus macaques with SIV or chimeric SHIV is routinely used as a model for AIDS. In such models, DNA immunization is a tool to elicit specific T cell responses and to study their protective efficacy. DNA immunogenicity in primates depends on parameters such as level of antigen expression, choice of the antigen among SIV proteins, use of fusion proteins, route of immunization, and addition of adjuvants. Recent results suggest that priming with DNA and boosting with attenuated recombinant viral vectors, each expressing corresponding SIV antigens, leads to improved specific immunity and, in some cases, affords protection against pathogenic challenge. After preclinical evaluations, DNA has entered clinical trials for a therapeutic or prophylactic gene-based AIDS vaccine.  相似文献